Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome

We studied eleven consecutive patients to assess the influence of extravascular lung water on clinical outcome. All patients were mechanically ventilated using a standardized protocol. Inspired oxygen concentration was adjusted to an initial target PaO2 of greater than 8.0 kPa (60.8 mmHg). All patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anaesthesia and intensive care 1999-08, Vol.27 (4), p.357-362
Hauptverfasser: DAVEY-QUINN, A, GEDNEY, J. A, WHITELEY, S. M, BELLAMY, M. C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 362
container_issue 4
container_start_page 357
container_title Anaesthesia and intensive care
container_volume 27
creator DAVEY-QUINN, A
GEDNEY, J. A
WHITELEY, S. M
BELLAMY, M. C
description We studied eleven consecutive patients to assess the influence of extravascular lung water on clinical outcome. All patients were mechanically ventilated using a standardized protocol. Inspired oxygen concentration was adjusted to an initial target PaO2 of greater than 8.0 kPa (60.8 mmHg). All patients received inhaled nitric oxide (NO) at a concentration of 20 ppm. Extravascular lung water index (EVLWI) was measured by a dual indicator technique (COLD Z-021 monitoring system, Pulsion, Munich, Germany). Patients were managed with fluids and inotropes according to a standard protocol. Median age was 45 (range 27-60) years, mean APACHE II score on admission 31 (range 17-36), duration of mechanical ventilation 15 (range 6-28) days, mean admission Murray lung injury score 2.5 (range 2-3) and admission EVLWI 20.8 (range 8.7 to 54.7) ml.kg-1. The only variables independently predictive of PaO2/FiO2 ratio were serum albumin (B = 1.7 +/- 1.61) and EVLWI (B = -2.1 +/- 0.47), r2 = 0.33, P < 0.0001. In severe ARDS, (PaO2/FiO2 < 150 mmHg), mean EVLWI was 24.4 (22.4 to 26.4, 95% confidence intervals) ml.kg-1 compared with 15.1 (12.2 to 18.0) ml.kg-1 during moderate ARDS (P < 0.001). Serum albumin likewise differed, 29.4 (27.6 to 31.2) vs 35.1 (31.8 to 38.4) g.l-1, P < 0.005. PAOP was higher during periods of poor oxygenation, 12.7 (11.9 to 13.5) vs 9.3 (7.9 to 10.7) mmHg, P < 0.001. The four survivors had greater initial EVLWI than non-survivors, 31 (24.1 to 37.9) vs 20.7 (16.0 to 25.4) ml.kg-1, P = 0.034 and showed a greater reduction in lung water, 15.2 (9.3 to 21.1) vs 5.4 (2.1 to 8.7) ml.kg-1, P = 0.013.
doi_str_mv 10.1177/0310057x9902700404
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70014477</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>44182823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-1e1c7300d880d067e4bd90e650ddcd0dd2ce8542a5d7f7413fd760400fb8ec093</originalsourceid><addsrcrecordid>eNpdkF1LwzAUhoMobk7_gBdSRLyrnqRp03gnY37AYDcK86pkSTo6unbmQ9d_b-YKE2_O4ZDnPZw8CF1iuMOYsXtIMEDKtpwDYQAU6BEaYkrzOMz4GA13QByI-QCdWbsCwJyw9BQNMFAGSZ4P0cdk64z4Elb6Wpio9s0y-hZOm0g0KhLSOx0ZbTeVEa41XaQq68JsI9s1yrRr_RDNtt1SN8JVbfMbar2T4eEcnZSitvqi7yP0_jR5G7_E09nz6_hxGsuEcxdjjSVLAFSeg4KMabpQHHSWglJShUKkzlNKRKpYyShOSsWy8FcoF7mWwJMRut3v3Zj202vrinVlpa5r0ejW2yKYCU4YC-D1P3DVetOE2wpCaE4pARIgsoekaa01uiw2ploL0xUYip31orc-P1gPoat-s1-stfoT2WsOwE0PBNGiLo1oZGUPHAfGkyz5AQBhilg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>224844202</pqid></control><display><type>article</type><title>Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><source>Alma/SFX Local Collection</source><creator>DAVEY-QUINN, A ; GEDNEY, J. A ; WHITELEY, S. M ; BELLAMY, M. C</creator><creatorcontrib>DAVEY-QUINN, A ; GEDNEY, J. A ; WHITELEY, S. M ; BELLAMY, M. C</creatorcontrib><description>We studied eleven consecutive patients to assess the influence of extravascular lung water on clinical outcome. All patients were mechanically ventilated using a standardized protocol. Inspired oxygen concentration was adjusted to an initial target PaO2 of greater than 8.0 kPa (60.8 mmHg). All patients received inhaled nitric oxide (NO) at a concentration of 20 ppm. Extravascular lung water index (EVLWI) was measured by a dual indicator technique (COLD Z-021 monitoring system, Pulsion, Munich, Germany). Patients were managed with fluids and inotropes according to a standard protocol. Median age was 45 (range 27-60) years, mean APACHE II score on admission 31 (range 17-36), duration of mechanical ventilation 15 (range 6-28) days, mean admission Murray lung injury score 2.5 (range 2-3) and admission EVLWI 20.8 (range 8.7 to 54.7) ml.kg-1. The only variables independently predictive of PaO2/FiO2 ratio were serum albumin (B = 1.7 +/- 1.61) and EVLWI (B = -2.1 +/- 0.47), r2 = 0.33, P &lt; 0.0001. In severe ARDS, (PaO2/FiO2 &lt; 150 mmHg), mean EVLWI was 24.4 (22.4 to 26.4, 95% confidence intervals) ml.kg-1 compared with 15.1 (12.2 to 18.0) ml.kg-1 during moderate ARDS (P &lt; 0.001). Serum albumin likewise differed, 29.4 (27.6 to 31.2) vs 35.1 (31.8 to 38.4) g.l-1, P &lt; 0.005. PAOP was higher during periods of poor oxygenation, 12.7 (11.9 to 13.5) vs 9.3 (7.9 to 10.7) mmHg, P &lt; 0.001. The four survivors had greater initial EVLWI than non-survivors, 31 (24.1 to 37.9) vs 20.7 (16.0 to 25.4) ml.kg-1, P = 0.034 and showed a greater reduction in lung water, 15.2 (9.3 to 21.1) vs 5.4 (2.1 to 8.7) ml.kg-1, P = 0.013.</description><identifier>ISSN: 0310-057X</identifier><identifier>EISSN: 1448-0271</identifier><identifier>DOI: 10.1177/0310057x9902700404</identifier><identifier>PMID: 10470388</identifier><identifier>CODEN: AINCBS</identifier><language>eng</language><publisher>Edgecliff: Anaesthesia and Intensive Care</publisher><subject>Administration, Inhalation ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Biological and medical sciences ; Emergency and intensive respiratory care ; Extravascular Lung Water - metabolism ; Female ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nitric Oxide - administration &amp; dosage ; Oxygen - administration &amp; dosage ; Oxygen - blood ; Positive-Pressure Respiration ; Pulmonary Gas Exchange ; Respiratory Distress Syndrome, Adult - metabolism ; Respiratory Distress Syndrome, Adult - mortality ; Respiratory Distress Syndrome, Adult - physiopathology ; Respiratory Distress Syndrome, Adult - therapy ; Serum Albumin - analysis ; Survival Rate ; Treatment Outcome</subject><ispartof>Anaesthesia and intensive care, 1999-08, Vol.27 (4), p.357-362</ispartof><rights>1999 INIST-CNRS</rights><rights>Copyright Australian Society of Anaesthetists Aug 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-1e1c7300d880d067e4bd90e650ddcd0dd2ce8542a5d7f7413fd760400fb8ec093</citedby><cites>FETCH-LOGICAL-c399t-1e1c7300d880d067e4bd90e650ddcd0dd2ce8542a5d7f7413fd760400fb8ec093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1907936$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10470388$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>DAVEY-QUINN, A</creatorcontrib><creatorcontrib>GEDNEY, J. A</creatorcontrib><creatorcontrib>WHITELEY, S. M</creatorcontrib><creatorcontrib>BELLAMY, M. C</creatorcontrib><title>Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome</title><title>Anaesthesia and intensive care</title><addtitle>Anaesth Intensive Care</addtitle><description>We studied eleven consecutive patients to assess the influence of extravascular lung water on clinical outcome. All patients were mechanically ventilated using a standardized protocol. Inspired oxygen concentration was adjusted to an initial target PaO2 of greater than 8.0 kPa (60.8 mmHg). All patients received inhaled nitric oxide (NO) at a concentration of 20 ppm. Extravascular lung water index (EVLWI) was measured by a dual indicator technique (COLD Z-021 monitoring system, Pulsion, Munich, Germany). Patients were managed with fluids and inotropes according to a standard protocol. Median age was 45 (range 27-60) years, mean APACHE II score on admission 31 (range 17-36), duration of mechanical ventilation 15 (range 6-28) days, mean admission Murray lung injury score 2.5 (range 2-3) and admission EVLWI 20.8 (range 8.7 to 54.7) ml.kg-1. The only variables independently predictive of PaO2/FiO2 ratio were serum albumin (B = 1.7 +/- 1.61) and EVLWI (B = -2.1 +/- 0.47), r2 = 0.33, P &lt; 0.0001. In severe ARDS, (PaO2/FiO2 &lt; 150 mmHg), mean EVLWI was 24.4 (22.4 to 26.4, 95% confidence intervals) ml.kg-1 compared with 15.1 (12.2 to 18.0) ml.kg-1 during moderate ARDS (P &lt; 0.001). Serum albumin likewise differed, 29.4 (27.6 to 31.2) vs 35.1 (31.8 to 38.4) g.l-1, P &lt; 0.005. PAOP was higher during periods of poor oxygenation, 12.7 (11.9 to 13.5) vs 9.3 (7.9 to 10.7) mmHg, P &lt; 0.001. The four survivors had greater initial EVLWI than non-survivors, 31 (24.1 to 37.9) vs 20.7 (16.0 to 25.4) ml.kg-1, P = 0.034 and showed a greater reduction in lung water, 15.2 (9.3 to 21.1) vs 5.4 (2.1 to 8.7) ml.kg-1, P = 0.013.</description><subject>Administration, Inhalation</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Emergency and intensive respiratory care</subject><subject>Extravascular Lung Water - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Oxygen - administration &amp; dosage</subject><subject>Oxygen - blood</subject><subject>Positive-Pressure Respiration</subject><subject>Pulmonary Gas Exchange</subject><subject>Respiratory Distress Syndrome, Adult - metabolism</subject><subject>Respiratory Distress Syndrome, Adult - mortality</subject><subject>Respiratory Distress Syndrome, Adult - physiopathology</subject><subject>Respiratory Distress Syndrome, Adult - therapy</subject><subject>Serum Albumin - analysis</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>0310-057X</issn><issn>1448-0271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkF1LwzAUhoMobk7_gBdSRLyrnqRp03gnY37AYDcK86pkSTo6unbmQ9d_b-YKE2_O4ZDnPZw8CF1iuMOYsXtIMEDKtpwDYQAU6BEaYkrzOMz4GA13QByI-QCdWbsCwJyw9BQNMFAGSZ4P0cdk64z4Elb6Wpio9s0y-hZOm0g0KhLSOx0ZbTeVEa41XaQq68JsI9s1yrRr_RDNtt1SN8JVbfMbar2T4eEcnZSitvqi7yP0_jR5G7_E09nz6_hxGsuEcxdjjSVLAFSeg4KMabpQHHSWglJShUKkzlNKRKpYyShOSsWy8FcoF7mWwJMRut3v3Zj202vrinVlpa5r0ejW2yKYCU4YC-D1P3DVetOE2wpCaE4pARIgsoekaa01uiw2ploL0xUYip31orc-P1gPoat-s1-stfoT2WsOwE0PBNGiLo1oZGUPHAfGkyz5AQBhilg</recordid><startdate>19990801</startdate><enddate>19990801</enddate><creator>DAVEY-QUINN, A</creator><creator>GEDNEY, J. A</creator><creator>WHITELEY, S. M</creator><creator>BELLAMY, M. C</creator><general>Anaesthesia and Intensive Care</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AYAGU</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19990801</creationdate><title>Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome</title><author>DAVEY-QUINN, A ; GEDNEY, J. A ; WHITELEY, S. M ; BELLAMY, M. C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-1e1c7300d880d067e4bd90e650ddcd0dd2ce8542a5d7f7413fd760400fb8ec093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Emergency and intensive respiratory care</topic><topic>Extravascular Lung Water - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Oxygen - administration &amp; dosage</topic><topic>Oxygen - blood</topic><topic>Positive-Pressure Respiration</topic><topic>Pulmonary Gas Exchange</topic><topic>Respiratory Distress Syndrome, Adult - metabolism</topic><topic>Respiratory Distress Syndrome, Adult - mortality</topic><topic>Respiratory Distress Syndrome, Adult - physiopathology</topic><topic>Respiratory Distress Syndrome, Adult - therapy</topic><topic>Serum Albumin - analysis</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAVEY-QUINN, A</creatorcontrib><creatorcontrib>GEDNEY, J. A</creatorcontrib><creatorcontrib>WHITELEY, S. M</creatorcontrib><creatorcontrib>BELLAMY, M. C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Australia &amp; New Zealand Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Anaesthesia and intensive care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAVEY-QUINN, A</au><au>GEDNEY, J. A</au><au>WHITELEY, S. M</au><au>BELLAMY, M. C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome</atitle><jtitle>Anaesthesia and intensive care</jtitle><addtitle>Anaesth Intensive Care</addtitle><date>1999-08-01</date><risdate>1999</risdate><volume>27</volume><issue>4</issue><spage>357</spage><epage>362</epage><pages>357-362</pages><issn>0310-057X</issn><eissn>1448-0271</eissn><coden>AINCBS</coden><abstract>We studied eleven consecutive patients to assess the influence of extravascular lung water on clinical outcome. All patients were mechanically ventilated using a standardized protocol. Inspired oxygen concentration was adjusted to an initial target PaO2 of greater than 8.0 kPa (60.8 mmHg). All patients received inhaled nitric oxide (NO) at a concentration of 20 ppm. Extravascular lung water index (EVLWI) was measured by a dual indicator technique (COLD Z-021 monitoring system, Pulsion, Munich, Germany). Patients were managed with fluids and inotropes according to a standard protocol. Median age was 45 (range 27-60) years, mean APACHE II score on admission 31 (range 17-36), duration of mechanical ventilation 15 (range 6-28) days, mean admission Murray lung injury score 2.5 (range 2-3) and admission EVLWI 20.8 (range 8.7 to 54.7) ml.kg-1. The only variables independently predictive of PaO2/FiO2 ratio were serum albumin (B = 1.7 +/- 1.61) and EVLWI (B = -2.1 +/- 0.47), r2 = 0.33, P &lt; 0.0001. In severe ARDS, (PaO2/FiO2 &lt; 150 mmHg), mean EVLWI was 24.4 (22.4 to 26.4, 95% confidence intervals) ml.kg-1 compared with 15.1 (12.2 to 18.0) ml.kg-1 during moderate ARDS (P &lt; 0.001). Serum albumin likewise differed, 29.4 (27.6 to 31.2) vs 35.1 (31.8 to 38.4) g.l-1, P &lt; 0.005. PAOP was higher during periods of poor oxygenation, 12.7 (11.9 to 13.5) vs 9.3 (7.9 to 10.7) mmHg, P &lt; 0.001. The four survivors had greater initial EVLWI than non-survivors, 31 (24.1 to 37.9) vs 20.7 (16.0 to 25.4) ml.kg-1, P = 0.034 and showed a greater reduction in lung water, 15.2 (9.3 to 21.1) vs 5.4 (2.1 to 8.7) ml.kg-1, P = 0.013.</abstract><cop>Edgecliff</cop><pub>Anaesthesia and Intensive Care</pub><pmid>10470388</pmid><doi>10.1177/0310057x9902700404</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0310-057X
ispartof Anaesthesia and intensive care, 1999-08, Vol.27 (4), p.357-362
issn 0310-057X
1448-0271
language eng
recordid cdi_proquest_miscellaneous_70014477
source MEDLINE; SAGE Complete A-Z List; Alma/SFX Local Collection
subjects Administration, Inhalation
Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
APACHE
Biological and medical sciences
Emergency and intensive respiratory care
Extravascular Lung Water - metabolism
Female
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Nitric Oxide - administration & dosage
Oxygen - administration & dosage
Oxygen - blood
Positive-Pressure Respiration
Pulmonary Gas Exchange
Respiratory Distress Syndrome, Adult - metabolism
Respiratory Distress Syndrome, Adult - mortality
Respiratory Distress Syndrome, Adult - physiopathology
Respiratory Distress Syndrome, Adult - therapy
Serum Albumin - analysis
Survival Rate
Treatment Outcome
title Extravascular lung water and acute respiratory distress syndrome: Oxygenation and outcome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A53%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extravascular%20lung%20water%20and%20acute%20respiratory%20distress%20syndrome:%20Oxygenation%20and%20outcome&rft.jtitle=Anaesthesia%20and%20intensive%20care&rft.au=DAVEY-QUINN,%20A&rft.date=1999-08-01&rft.volume=27&rft.issue=4&rft.spage=357&rft.epage=362&rft.pages=357-362&rft.issn=0310-057X&rft.eissn=1448-0271&rft.coden=AINCBS&rft_id=info:doi/10.1177/0310057x9902700404&rft_dat=%3Cproquest_cross%3E44182823%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=224844202&rft_id=info:pmid/10470388&rfr_iscdi=true